⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLGN News
CollPlant Biotechnologies Ltd Ordinary Shares
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS USA - English USA - español
prnewswire.com
CLGN
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
prnewswire.com
CLGN
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
prnewswire.com
CLGN
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
prnewswire.com
CLGN
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
prnewswire.com
CLGN
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
prnewswire.com
CLGN
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
prnewswire.com
CLGN
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
prnewswire.com
CLGN
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
prnewswire.com
CLGN
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
prnewswire.com
CLGN